濮阳东方医院男科治疗阳痿可靠(濮阳东方妇科医院做人流手术便宜吗) (今日更新中)

SAN FRANCISCO, April 5 (Xinhua) -- The appeal of tablet computer and electronic-book reader (e-reader) has been giving a boost to semiconductor market as sales of chips for such devices surged in 2010 and keeps growing, market research firm International Data Corp. (IDC) said on Tuesday.A new IDC report showed that worldwide revenues for media tablet and e-reader semiconductors grew by over 2,000 percent to 3. 3 billion U.S. dollars in 2010 as semiconductor suppliers enabled original equipment manufacturers to bring new products to market less than 8 months after Apple Inc. launched its iPad tablet.According to IDC's definition, media tablets are devices with color displays larger than 5-inch and smaller than 14-inch, running lightweight operating systems and able to be based on either x86 or ARM processors."The opportunity for semiconductors in media tablets and e- readers has exploded and semiconductor suppliers are scrambling to bring to market semiconductor and software platforms to enable these products," Michael Palma, a senior research analyst at IDC, said in a statement.Looking forward, IDC said it expects media tablet and e-reader semiconductor revenues to grow by 120 percent year over year in 2011, predicting that the market will be boosted by the arrival of a new version of Google Inc.'s Android operating system, dual core processors and increased bandwidth."For the next several years, we will see rapid innovation cycles for products launched into the marketplace and semiconductor suppliers will continue to satisfy evolving end user requirements over the coming years," Palma noted.

BEIJING, March 14 (Xinhuanet) – "Angry Birds" game developers at Rovio have announced a funding of 42 million U.S. dollars to expand their "mean pigs, cranky birds" empire, according to foreign media report Sunday.The funding, announced Thursday, is the first venture-capital money Rovio has secured. Richard Wong with Accel Partners, who led the firm's investment in Rovio, hailed "Angry Birds" as "an incredible consumer franchise beyond just being a mobile game."With the newly raised funding, "Angry Birds" developers have made a strategic plan to achieve the brand growth of "Angry Birds."According to developer Peter "Mighty Eagle" Vesterbacka, Rovio is going to expand the franchise of "Angry Birds" in a lot of directions such as movie, broadcast and TV."We are working on a game that will involve Facebook ... really the plan is to make "Angry Birds" playable everywhere," said Vesterbacka. Besides its efforts in digital realm, Rivio is also exploring the potential toy market. Ravio has already sold over two million "Angry Birds" plush toys, which have broken into the mainstream retail channels. Recently Ravio has also branched out into selling "Angry Bird" apparel."Angry Birds", hatched in 2009, has dominated Apple's list of top-selling iPhone apps since it took flight last year. It is now available on many other platforms -- iPad, Android, iTouch, and almost every other smartphone out there.The game became world-polupar as it is easy to pick up and very addictive. Rovio, a mobile game development studio founded in Finland in 2003, enjoys the reputation as one of the most innovative game shops in Europe.

BEIJING, May 21 (Xinhua) -- China's State Food and Drug Administration (SFDA) issued a circular on Friday banning the use of Nimesulide, an anti-inflammatory drug, for children under the age of 12, considering potential side-effects such as liver and kidney damage.Nimesulide is a non-steroidal anti-inflammatory drug that first became available in Italy in 1985. It is now used in more than 50 countries and regions.The drug entered Chinese markets in 1997.According to the SFDA, while common adverse reactions to the drug include vomiting and stomache, domestic and overseas statistics indicate that more severe issues are related to the drug, such as blood coagulation disorders, decreased white blood cells and damage to liver and kidney.Previously, the SFDA only prevented the use of the drug among children one year old or younger.Also on Friday, the SFDA ordered the suspension of the production, sales and use of Duxil (almitrine and raubasine compound) due to its "unobvious" efficacy.According to the SFDA, clinical research found "little" evidence proving the drug effectively improves the cognitive ability for patients suffering vascular cognitive impairment.The drug was supposed to treat symptoms related to cognition and sensory nerve damage.The moves came after a two-month nationwide campaign was launched earlier this month to probe the quality of essential drugs and ensure drug safety.Official figures show that China's National Center for Adverse Drug Reaction Monitoring received 692,904 reports of adverse reactions in 2010, up 8.4 percent compared with those in 2009.Among the total, 109,991 cases involved new or severe adverse reactions, a year-on-year increase of 16.2 percent.

BEIJING, Feb. 10 (Xinhua) -- The Chinese currency, or the yuan, on Thursday rose to a fresh high of 6.5849 against the U.S. dollar, according to the China Foreign Exchange Trading System.The central parity rate of the yuan, or RMB, was 1 basis point higher than the previous record of 6.585 set on Feb. 9, the previous trading day.The central parity rate has risen against the dollar for a three consecutive trading days.China's central bank announced on June 19 last year that it would further reform the yuan exchange rate formation mechanism to improve its flexibility.On China's foreign exchange spot market, the yuan can rise or fall 0.5 percent from the central parity rate each trading day.The central parity rate of the RMB against the U.S. dollar is based on a weighted average of prices before the opening of the market each business day.

WASHINGTON, May 11 (Xinhua) -- Johns Hopkins University researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.The work, published Wednesday in the journal Science Translational Medicine, suggests that liver cells derived from so- called "induced-pluripotent stem cells (iPSCs)" could one day be used as an alternative to liver transplant in patients with serious liver diseases, bypassing long waiting lists for organs and concerns about immune system rejection of donated tissue."Our findings provide a foundation for producing functional liver cells for patients who suffer liver diseases and are in need of transplantation," says Yoon-Young Jang, assistant professor of oncology at the Johns Hopkins Kimmel Cancer Center. "iPSC-derived liver cells not only can be generated in large amounts, but also can be tailored to each patient, preventing immune-rejection problems associated with liver transplants from unmatched donors or embryonic stem cells." A microsopic view shows human embryonic stem cells in various stages of differentiation into liver cells in this photo taken at Stanford University and released by the California Institute for Regenerative Medicine, March 9, 2009iPSCs are made from adult cells that have been genetically reprogrammed to revert to an embryonic stem cell-like state, with the ability to transform into different cell types. Human iPSCs can be generated from various tissues, including skin, blood and liver cells.Although the liver can regenerate in the body, end-stage liver failure caused by diseases like cirrhosis and cancers eventually destroy the liver's regenerative ability, Jang says. Currently, the only option for those patients is to receive a liver organ or liver cell transplant, a supply problem given the severe shortage of donor liver tissue for transplantation. In addition, mature liver cells and adult liver stem cells are difficult to isolate or grow in the laboratory, she says. By contrast, iPSCs can be made from a tiny amount of many kinds of tissue; and the embryonic stem- like iPSCs can grow in laboratory cultures indefinitely.For the study, Jang and colleagues generated human iPSCs from a variety of adult human cells, including liver cells, fibroblasts ( connective tissue cells), bone marrow stem cells and skin cells. They found that though the iPSCs overall were molecularly similar to each other and to embryonic stem cells, they retained a distinct molecular "signature" inherited from the cell of origin.

来源：资阳报